To analyze our surgical management and the result of squamous cell carcinoma (SCC) of vulva. Retrospectively, we collected 38 cases of SCC; 17 cases of them were early SCC and 21 cases were locally advanced. The patients underwent primary surgery. The survival was estimated using Kaplan-Meier analysis and the log rank test. The mean age was 60.78 years. Total vulvectomy was performed in all patients. Superficial and deep incision of bilateral inguinal lymphadenectomy was performed by separates incisions for SCC infiltrating more than 1mm. The average tumor size was 53 mm (10 to 140mm). Morbidity was 42.1%. Lateral resection margin ≥8mm was obtained in 57.1%. Eighteen patients benefited from adjuvant radiotherapy. The follow-up median was 19.4 months (6 to 61.5 month) with 05 recurrences in 12 months. The survival using the KaplanMeyer analysis at 5 years, was 62.1% (71.2%N -vs 46.7%N + ; p = 0.13). We identified two groups for locally advanced vulva cancer. Primary surgery keeps its place. Neo adjuvant radio chemotherapy followed by surgery is the alternative treatment for locally extensive lesions.
Introduction
quamous cell carcinoma (SCC) of vulva is a rare cancer. It represents 3-5% of gynecological cancers with an incidence of 2 per 100 000 women/year [1] . It affects women of the 6th decade.
Surgery remains the cornerstone of its management. The treatment is well codified for the early stages whereas locally advanced carcinomas (stage III and IV) may be difficult to manage. The morbidity of this inguinal vulvar surgery may be important. It sometimes includes durable and disabling sequels. Also, radiotherapy and/or chemotherapy progressively find more important place in the treatment of localized SCC of vulva. In the light of literature data, we present our series of 38 cases of vulvar SCC, discuss our result and therapeutic indications especially in locally advanced stages which management is not yet codified.
Methods
We undertook a retrospective descriptive study between 
Results

Clinical description
The mean age of patients was 60.78 years (32 to 91 years). The size of the tumor, its location and local extension are summarized in 
Surgery
The first total vulvectomy was performed in all patients. The resection was sometimes extended to the urethral meat (5 cases), to vagina (6 cases), and/or to perineum (2 cases). The length of the urethra resected was less than 1cm in 2 cases, one case between 1 cm and 1.5 cm, and more than 1. Table 2 .
Anatomo-pathological findings and pTNM classification
Twenty-seven (27) patients were classified at least pT2. We for lesions infiltrating more than 1mm. In our study, it was an excessive surgery for such unifocal tumors which size was inferior to 2 cm. In case of less mutilating resection with a macroscopic margin of 1 cm to 2 cm, no significant difference was found in terms of recurrence and mortality, compared to radical vulvectomy [7] .
Lymphadenectomy was the only way referenced that could give us full histological analysis of the inguinal nodes. Its complications are frequent and often disabling [5, 6, 8] : suture dehiscence (13-38%), seroma (12-40%), secondary infection (22-57%) and lymphedema (13-53%). As economical consequence, there is an increase of the average length of stay.
Locally advanced SCC of vulva requires first extensive surgery. It is recommended to obtain a macroscopic surgical margin superior to 2 cm [4, 8, 9] in order to minimize the probability of obtaining a pathological margin under 10 mm. Authors [4, 9, 10] have reported that histological margin < 8mm was accompanied with a recurrence rate of 23% to 52.6%. In our series, we noted 34% of extensive surgery with resection of the distal urethra, vagina and perineum.
The margin of lateral resection ≥8mm (only 57.1% in our series) was more difficult to obtain in locally advanced SCC. Direct morbidity consisted in disunity of the suture by tension or superinfection, delayed wound healing, and urinary incontinence.
Despite a complete inguinal lymphadenectomy, the risk of inguinal recurrence still exists. After 12 months follow-up, the recurrence rate in our series was 13.2%. Risk factors of recurrence in our study were: tumor size ≥40 mm, lack of inguinal lymphadenectomy, lack of adjuvant radiotherapy, and refusal of treatment (in 04 elderly patients). The Spanish Society of Obstetrics and Gynecologist (SEGO) considers 40 mm the limit between tumors with high and low risk [11] . The Risk factors for local and inguinal recurrence are tumor size (≥35mm), margin of resection (≤15mm), degree of invasion (4mm) and initial nodal involvement [10] . In the literature, the overall survival is 70% to 93% (N -) and 25% to 41% (N + ) [12, 13] . In our series, primary surgery followed by radiation 
Conclusion
The optimal management of advanced vulva cancer is complex and 
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